Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Louisiana for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Louisiana only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Louisiana (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Aaron Broadwell (NPI 1851554786)

Field	Value
Entity Type	Individual
Organization	Aaron Broadwell
Address	820 Jordan St
City	Shreveport
State	LA
ZIP	71101
Taxonomy	Rheumatology Physician
NPI Enumerated	July 10, 2008

Payer Source	Total Paid
Medicare	$6.4M
Medicaid	$0

Key Findings

This provider is effectively single‑payer in the claims record: Total Medicare revenue: $6.4M while Total Medicaid revenue: none (no Medicaid billing on file). Operational and competitive analysis should therefore be oriented to Medicare activity and the absence of Medicaid billing limits in‑state payer comparisons.

Revenue is highly concentrated in a small set of biologic/injectable drug codes: the top three Medicare codes (J1602, J0129, J0897) together account for 62.9% of this provider's total Medicare revenue. Specifically, J1602 $2.1M revenue (33.2% of this provider's total Medicare revenue), J0129 $1.1M revenue (18.1% of this provider's total Medicare revenue), and J0897 $732.3K revenue (11.6% of this provider's total Medicare revenue) drive the bulk of dollars.

The code mix points to a practice built around physician‑supervised administration of biologics and imaging‑supported musculoskeletal care rather than primarily office‑based procedures alone. J1602 (golimumab), J0129 (abatacept) and J0897 (denosumab) are all high‑cost injectable biologics administered under supervision, and the presence of high‑volume imaging and DXA codes suggests integrated infusion plus diagnostic services on site.

For several high‑revenue biologic codes this provider is a national outlier: J1602 ranks #1 of 1041 providers nationally (100th percentile; extreme outlier), J0897 ranks #40 of 10057 providers nationally (100th percentile; extreme outlier), and J0129 ranks #35 of 1221 providers nationally (97th percentile; notably above typical national volume). These rank/percentile positions indicate dominant national standing for selected infused biologics and unusually large drug‑administration volumes versus peers.

The practice also reports extremely high utilization of certain diagnostic and imaging services that typically support musculoskeletal and rheumatologic care, implying in‑house capability. 76881 $103.3K revenue (1.6% of this provider's total Medicare revenue) ranks #5 of 1606 providers nationally (100th percentile; extreme outlier), and multiple X‑ray codes such as 73100 $22.1K revenue and 73130 $23.3K revenue are also at or near the 100th percentile, suggesting an integrated imaging suite materially contributes to revenue.

There is a notable infusion/chemotherapy administration footprint beyond routine rheumatology injections: chemotherapy administration codes 96413 $169.8K revenue (2.7% of this provider's total Medicare revenue) and 96401 $80.3K revenue (1.3% of this provider's total Medicare revenue) rank as extreme outliers (96413 #6 of 7514 providers, 100th percentile; 96401 #17 of 3868 providers, 100th percentile). While the provider is listed as Rheumatology Physician, these codes are consistent with substantial parenteral therapy and infusion services frequently used in autoimmune disease management.

Evaluation-and-management volumes are also elevated, consistent with a high visit throughput and ongoing management of complex patients: 99214 $122.8K revenue (1.9% of this provider's total Medicare revenue) ranks #4521 of 479517 providers nationally (99th percentile; extreme outlier), and 99215 $53K revenue (0.8% of this provider's total Medicare revenue) ranks #2882 of 145531 providers nationally (98th percentile; notably above typical national volume). This pattern supports a business model of frequent follow‑up and medically complex outpatient care alongside infusion services.

The provider has a long tenure in the NPI file, enumerated on 2008-07-10 (~18 years ago), which aligns with an established practice likely to have developed the referral relationships and capital (infusion and imaging capability) reflected in the high volumes of biologics and diagnostic services. Analysts should consider this longevity when assessing competitive positioning and the sustainability of current service lines.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

44 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J1602	Injection, golimumab, 1 mg, for intravenous use	209,760	$10	$2.1M
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	33,630	$30	$1.1M
J0897	Injection, denosumab, 1 mg	40,690	$20	$732.3K
J0717	Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	107,410	$1	$429.6K
J3262	Injection, tocilizumab, 1 mg	72,060	$10	$360.3K
J3245	Injection, tildrakizumab, 1 mg	2,800	$110	$308K
J3111	Injection, romosozumab-aqqg, 1 mg	34,230	$10	$273.8K
J9312	Injection, rituximab, 10 mg	3,770	$60	$226.2K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	1,850	$90	$169.8K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	1,400	$90	$122.8K

Showing 1–10 of 44

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 44 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Louisiana Distribution

Aaron Broadwell — 15 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Louisiana

Full comparison — all codes billed, vs. state median

44 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J1602	1	10	26,920	$10	$526.5K
J0129	2	10	9,490	$30	$506.1K
J3262	2	10	55,770	$1	$329.7K
J3245	1	10	2,800	$110	$308.9K
J0717	4	10	55,200	$1	$263K
J9312	2	10	3,770	$60	$233.2K
J3111	2	10	16,800	$10	$161.1K
J0897	2	70	3,120	$20	$105.6K
J1745	5	10	3,110	$30	$80K
96413	1	70	140	$90	$22.8K

Showing 1–10 of 44

Related Providers

Other providers that share a Tax Identification Number (TIN) with Aaron Broadwell, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Larry Broadwell	LA	Rheumatology Physician	$5M	$0
Frankie Pedigo	LA	Rheumatology Physician	$1.2M	$0
Mary Walton	LA	Rheumatology Physician	$952.9K	$0
Mamatha Katikaneni	LA	Rheumatology Physician	$473.3K	$0
Emily Bergeron	LA	Physician Assistant	$11.9K	$0

Nearby Providers

Other providers in the same ZIP code as Aaron Broadwell, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
The Arc Caddo Bossier	LA	Health Maintenance Organization	$0	$37.3M
Volunteers Of America Of North Louisiana	LA	Developmentally Disabled Services Day Training Agency	$0	$24.2M
City Of Shreveport	LA	Ambulance	$1.5M	$20.2M
Assisted Family Services, LLC.	LA	In Home Supportive Care Agency	$0	$19.8M
Ochsner Lsu Health Shreveport - St. Mary Medical Center, LLC	LA	Women's Hospital	$0	$15M
Volunteers Of America Of North Louisiana	LA	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$12.5M
Brentwood Acquisition-shreveport Inc.	LA	Psychiatric Hospital	$0	$11.2M
Easter Seals Louisiana Inc.	LA	Case Management Agency	$0	$9.8M
Center For Behavioral Health Louisiana LLC	LA	Methadone Clinic	$299.3K	$7.1M
Progressive Childrens Clinic LLC	LA	Pediatrics Physician	$0	$6.1M

Aaron Broadwell — Billing Profile & Reimbursement Data

Sign up for Aaron Broadwell — Billing Profile & Reimbursement Data policy alerts

Aaron Broadwell — Billing Profile & Reimbursement Data

Sign up for Aaron Broadwell — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References